A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections
Recruiting
Phase 1
Interventional Study
Surgical Wound Infection
Traumatic Wound Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 79
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 44 (estimated)
- Sponsor
- Macro Biologics, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this Phase 1 clinical trial is to learn about the safety profile of Amicidin-β topical solution applied directly into infected surgical or traumatic wounds during a surgical procedure. The main questions it aims to answer are:
1. Is Amicidin-β topical solution safe to test in larger clinical trials?
2. Is Amicidin-β topical solution absorbed into the bloodstream from local wound appli…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Main Inclusion Criteria:
* Body Mass Index between 18.5 kg/square meter and 39.9kg/square meter
* Surgical or traumatic wound determined by the Investigator to be infected within 90 days of surgery or trauma, with longest dimension between 3 and 15 cm. The diagnosis should include one or more of th…
Contacts